Gastrohepatic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

H. pylori Elimination and Gastric Cancer

Targeting the bacteria Helicobacter pylori with a short course of combination therapy may help decrease the risk of gastric cancer.

Surgery vs. Rx Therapy for UC

In a new study, some patients with advanced ulcerative colitis (UC) had better outcomes with elective colectomy compared to immunosuppressant therapy, even though this is typically a treatment of last resort.

FDA: Antiemetic Shortage Announced

The Food and Drug Administration (FDA) announced that Emend (aprepitant; Merck) is currently in shortage.

Some Antacids Linked to Heart Attack

Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16-21% compared to those who don't use commonly prescribed antacids, a large study has found.

Viberzi, Xifaxan for IBS-D Now FDA-Approved

The FDA has approved Viberzi (eluxadoline; Actavis) and Xifaxan 550mg (rifaximin; Salix) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

Oral C. difficile Reduces CDI Recurrence

A non-aggressive Clostridium difficile strain significantly reduced the risk of Clostridium difficile infection (CDI) recurrence in a small study published in the Journal of the American Medical Association.

Relaxation Response Improves IBS, IBD Symptoms

In the first study to assess the use of the relaxation response for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), a nine-week training program including use of the relaxation response had a significant impact on the clinical symptoms of these disorders.

Diabetes Drug: First NASH Approved Treatment? ...

A medication indicated to treat type 2 diabetes could be a future therapeutic option for non-alcoholic steatohepatitis (NASH) after a study met its primary endpoint of histological clearance of NASH, and a reduction in the progression of fibrosis.

Featured courses from mycme

Novel Basal Insulin Works, But Liver Risks CitedExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

New-Drug Briefs (June 2015)External web site

June 2015 New-Drug Briefs

CME 1.00 Credits

ACP: Less Screening Is Better in Most AdultsExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters